Pei‐Ming Chu

1.1k total citations
31 papers, 910 citations indexed

About

Pei‐Ming Chu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Pei‐Ming Chu has authored 31 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Pei‐Ming Chu's work include Cancer-related molecular mechanisms research (5 papers), Galectins and Cancer Biology (4 papers) and MicroRNA in disease regulation (3 papers). Pei‐Ming Chu is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Galectins and Cancer Biology (4 papers) and MicroRNA in disease regulation (3 papers). Pei‐Ming Chu collaborates with scholars based in Taiwan, Vietnam and Hong Kong. Pei‐Ming Chu's co-authors include Kun‐Ling Tsai, Pei‐Ling Hsieh, Ching‐Hsia Hung, Shih‐Hung Chan, Cheng‐Chia Yu, Hsiu‐Chung Ou, Wan‐Ching Chou, Yi‐Wen Liao, Thi Thuy Tien Vo and I‐Ta Lee and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Ethnopharmacology and Oncotarget.

In The Last Decade

Pei‐Ming Chu

31 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pei‐Ming Chu Taiwan 18 380 134 93 92 88 31 910
Jau‐Shyang Huang Taiwan 20 416 1.1× 80 0.6× 108 1.2× 90 1.0× 31 0.4× 35 1.1k
Eswar Shankar United States 24 799 2.1× 292 2.2× 91 1.0× 77 0.8× 31 0.4× 50 1.4k
Hsiang‐Tsui Wang Taiwan 20 600 1.6× 212 1.6× 279 3.0× 94 1.0× 36 0.4× 47 1.3k
In-Sun Park South Korea 15 255 0.7× 75 0.6× 67 0.7× 143 1.6× 18 0.2× 22 876
Irena Kasacka Poland 19 309 0.8× 77 0.6× 168 1.8× 87 0.9× 13 0.1× 135 1.2k
Rufeng Ma China 16 657 1.7× 90 0.7× 116 1.2× 89 1.0× 10 0.1× 24 1.3k
Caroline Maria Oliveira Volpe Brazil 11 422 1.1× 71 0.5× 199 2.1× 181 2.0× 13 0.1× 28 1.4k
Yang Zheng China 19 483 1.3× 74 0.6× 199 2.1× 145 1.6× 14 0.2× 40 1.2k
Chao-Chien Chang Taiwan 15 195 0.5× 66 0.5× 41 0.4× 52 0.6× 22 0.3× 29 543

Countries citing papers authored by Pei‐Ming Chu

Since Specialization
Citations

This map shows the geographic impact of Pei‐Ming Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei‐Ming Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei‐Ming Chu more than expected).

Fields of papers citing papers by Pei‐Ming Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei‐Ming Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei‐Ming Chu. The network helps show where Pei‐Ming Chu may publish in the future.

Co-authorship network of co-authors of Pei‐Ming Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Pei‐Ming Chu. A scholar is included among the top collaborators of Pei‐Ming Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei‐Ming Chu. Pei‐Ming Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsai, Hung‐Wen, Yili Chen, Chun‐I Wang, et al.. (2023). Anterior gradient 2 induces resistance to sorafenib via endoplasmic reticulum stress regulation in hepatocellular carcinoma. Cancer Cell International. 23(1). 42–42. 11 indexed citations
2.
Tsai, Hung‐Wen, Yili Chen, Chun‐I Wang, et al.. (2023). Cisplatin or Doxorubicin Reduces Cell Viability via the PTPIVA3-JAK2-STAT3 Cascade in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 10. 123–138. 3 indexed citations
3.
Chou, Wan‐Ching, et al.. (2023). Sesamin suppresses angiotensin‐II‐enhanced oxidative stress and hypertrophic markers in H9c2 cells. Environmental Toxicology. 38(9). 2165–2172. 8 indexed citations
4.
Chen, Yili, et al.. (2023). Roles of protein tyrosine phosphatases in hepatocellular carcinoma progression (Review). Oncology Reports. 49(3). 10 indexed citations
5.
Chu, Pei‐Ming, Cheng‐Chia Yu, Kun‐Ling Tsai, & Pei‐Ling Hsieh. (2022). Regulation of Oxidative Stress by Long Non-Coding RNAs in Vascular Complications of Diabetes. Life. 12(2). 274–274. 23 indexed citations
6.
Hsieh, Pei‐Fang, et al.. (2021). Verbascoside Protects Gingival Cells against High Glucose-Induced Oxidative Stress via PKC/HMGB1/RAGE/NFκB Pathway. Antioxidants. 10(9). 1445–1445. 17 indexed citations
7.
Hsieh, Pei‐Fang, et al.. (2021). Long Non-Coding RNA MEG3 in Cellular Stemness. International Journal of Molecular Sciences. 22(10). 5348–5348. 19 indexed citations
8.
Peng, Chih‐Yu, Cheng‐Chia Yu, Yi‐Wen Liao, et al.. (2021). Magnolol inhibits cancer stemness and IL-6/Stat3 signaling in oral carcinomas. Journal of the Formosan Medical Association. 121(1). 51–57. 28 indexed citations
9.
Ho, Tsung‐Jung, et al.. (2021). Cordycepin Attenuates Palmitic Acid-Induced Inflammation and Apoptosis of Vascular Endothelial Cells through Mediating PI3K/Akt/eNOS Signaling Pathway. The American Journal of Chinese Medicine. 49(7). 1703–1722. 15 indexed citations
10.
Wang, Chun‐I, et al.. (2021). Chemotherapeutic Drug-Regulated Cytokines Might Influence Therapeutic Efficacy in HCC. International Journal of Molecular Sciences. 22(24). 13627–13627. 25 indexed citations
11.
12.
Lin, Taichen, Cheng‐Chia Yu, Yi‐Wen Liao, et al.. (2020). miR-200a inhibits proliferation rate in drug-induced gingival overgrowth through targeting ZEB2. Journal of the Formosan Medical Association. 119(8). 1299–1305. 4 indexed citations
13.
14.
Lee, Chiang‐Wen, Miao‐Ching Chi, Lee‐Fen Hsu, et al.. (2019). Carbon monoxide releasing molecule-2 protects against particulate matter-induced lung inflammation by inhibiting TLR2 and 4/ROS/NLRP3 inflammasome activation. Molecular Immunology. 112. 163–174. 28 indexed citations
15.
Tsai, Kun‐Ling, Ching‐Hsia Hung, Pei‐Ling Hsieh, et al.. (2018). Chlorogenic Acid Protects Against oxLDL‐Induced Oxidative Damage and Mitochondrial Dysfunction by Modulating SIRT1 in Endothelial Cells. Molecular Nutrition & Food Research. 62(11). e1700928–e1700928. 86 indexed citations
16.
Lin, Che-Yi, Yi‐Wen Liao, Pei‐Ling Hsieh, et al.. (2017). LncRNA GAS5-AS1 inhibits myofibroblasts activities in oral submucous fibrosis. Journal of the Formosan Medical Association. 117(8). 727–733. 43 indexed citations
17.
Hung, Ching‐Hsia, Shih‐Hung Chan, Pei‐Ming Chu, & Kun‐Ling Tsai. (2015). Quercetin is a potent anti‐atherosclerotic compound by activation of SIRT1 signaling under oxLDL stimulation. Molecular Nutrition & Food Research. 59(10). 1905–1917. 134 indexed citations
18.
Lin, Yi-Hui, Yu‐Chun Huang, Li‐Hsin Chen, & Pei‐Ming Chu. (2014). Autophagy in cancer stem/progenitor cells. Cancer Chemotherapy and Pharmacology. 75(5). 879–886. 13 indexed citations
19.
Lin, Shiuan-Pey, et al.. (2012). Pharmacokinetics and tissue distribution of resveratrol, emodin and their metabolites after intake of Polygonum cuspidatum in rats. Journal of Ethnopharmacology. 144(3). 671–676. 55 indexed citations
20.
Chu, Pei‐Ming, et al.. (2004). Experimental and modeling studies of radiocesium retention in soils. Journal of Radioanalytical and Nuclear Chemistry. 262(2). 339–344. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jau‐Shyang Huang Breakdown of academic impact, for papers by Eswar Shankar Breakdown of academic impact, for papers by Hsiang‐Tsui Wang Breakdown of academic impact, for papers by In-Sun Park Breakdown of academic impact, for papers by Irena Kasacka Breakdown of academic impact, for papers by Rufeng Ma Breakdown of academic impact, for papers by Caroline Maria Oliveira Volpe Breakdown of academic impact, for papers by Yang Zheng Breakdown of academic impact, for papers by Chao-Chien Chang
Rankless by CCL
2026